MMED (Minimed Group) Total Stockholders Equity: $3,611 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MMED Minimed Group Inc MMED
15 GF Score
Price $19.85
! 3 Warning Signs
View Full Analysis

What is Minimed Group Total Stockholders Equity?

Minimed Group MMED +1.77% 15 Total Stockholders Equity is $3,611 Mil as of Apr. 2026. GuruFocus rates MMED with a GF Score™ of 15/100. The stock has 3 warning signs investors should review.

Minimed Group's Total Stockholders Equity for the quarter that ended in Apr. 2026 was $3,611 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Minimed Group's Book Value per Share for the quarter that ended in Apr. 2026 was $12.86. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Minimed Group's Debt-to-Equity for the quarter that ended in Apr. 2026 was 0.04.


Minimed Group  (NAS:MMED) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Minimed Group's Book Value per Share for the quarter that ended in Apr. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Minimed Group's Debt-to-Equity for the quarter that ended in Apr. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Minimed Group Total Stockholders Equity Related Terms


Minimed Group Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Minimed Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minimed Group Total Stockholders Equity Chart

Minimed Group Annual Data
Trend Apr23 Apr24 Apr25 Apr26
Total Stockholders Equity
0.00 3,448.00 3,331.00 3,611.00

Minimed Group Quarterly Data
Apr24 Jan25 Apr25 Oct25 Jan26 Apr26
Total Stockholders Equity Get a 7-Day Free Trial 0.00 3,331.00 3,744.00 3,463.00 3,611.00
MMED
15GF Score
Minimed Group Inc MMED
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $3,611 Mil mean?
Minimed Group (MMED) has a Total Stockholders Equity of $3,611 Mil as of Apr. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Minimed Group and its competitors.
Is Minimed Group's Total Stockholders Equity too high?
Minimed Group's current Total Stockholders Equity is $3,611 Mil. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Total Stockholders Equity compare to MMSI and NVST?
Minimed Group's Total Stockholders Equity of $3,611 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Minimed Group and its competitors. Minimed Group's current Total Stockholders Equity is $3,611 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (MMED) has a current Total Stockholders Equity of $3,611 Mil. The current Total Stockholders Equity is $3,611 Mil. Minimed Group's overall GF Score™ is 15/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Minimed Group (MMED), the current Total Stockholders Equity is $3,611 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minimed Group Business Description

Other Exchanges B8S:Germany
Address 18000 Devonshire Street, Northridge, CA, USA, 91325
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score

Get the complete analysis for MMED

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.85
Price